Genor Biopharma targets $371m from Hong Kong IPO

By Jonathan Breen
23 Sep 2020

JHBP (CY) Holdings, a holding company for China’s Genor Biopharma, hit the road for its Hong Kong IPO on Wednesday. It is aiming to raise up to HK$2.9bn ($371.2m).

Goldman Sachs, Jefferies and JP Morgan, the sponsors and global co-ordinators, kicked off bookbuilding for an offer of 119.9m shares. The float has initially been split 90% to international investors and the balance to local retail accounts.

Genor, a Chinese biopharmaceuticals company, is offering the stock at ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial